An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.
- DOI
- 10.1016/j.omton.2025.201030
- Published
- 2025-08-06
- Container
- Mol Ther Oncol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omton.2025.201030,
title = {An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.},
author = {Jackson JW and Hall BL and Sneiderman C and Webb A and Hancock TJ and Vlasyuk M and Bailey L and Xiaokui M and Solomon IH and Ligon K and Goins WF and Kohanbash G and Chiocca EA and Glorioso JC.},
year = {2025},
journal = {Mol Ther Oncol},
doi = {10.1016/j.omton.2025.201030},
url = {https://doi.org/10.1016/j.omton.2025.201030}
}RIS
TY - JOUR TI - An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma. AU - Jackson JW AU - Hall BL AU - Sneiderman C AU - Webb A AU - Hancock TJ AU - Vlasyuk M AU - Bailey L AU - Xiaokui M AU - Solomon IH AU - Ligon K AU - Goins WF AU - Kohanbash G AU - Chiocca EA AU - Glorioso JC. PY - 2025 JO - Mol Ther Oncol DO - 10.1016/j.omton.2025.201030 UR - https://doi.org/10.1016/j.omton.2025.201030 ER -
APA
JW, J., BL, H., C, S., A, W., TJ, H., M, V., L, B., M, X., IH, S., K, L., WF, G., G, K., EA, C., & JC., G. (2025). An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.. Mol Ther Oncol. https://doi.org/10.1016/j.omton.2025.201030
Source records
- europe-pmc · retrieved 2026-09-26T10:33:09.611Z
- doaj · retrieved 2026-09-26T10:33:09.588Z